Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Research Report 2021, Forecast to 2026

Code: RW00014653558
Multimarket Insight
Nov-2021
Life Sciences
133 Pages

We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.

Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.

Market Segment by Product Type
Invokana (Canagliflozin)
Jardiance (Empagliflozin)
Farxiga/Forxiga (Dapagliflozin)
Suglat (Ipragliflozin)

Market Segment by Product Application
Hospital
Medical Research Institute
Other

Finally, the report provides detailed profile and data information analysis of leading company.
Eli Lilly
Janssen Pharmaceuticals
Astellas
Boehringer Ingelheim
AstraZeneca
Bristol Myers Squibb
Kotobuki Pharmaceutical

Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.

Research Objectives
1.To study and analyze the global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors consumption (value) by key regions/countries, product type and application, history data from 2016 to 2020, and forecast to 2026.
2.To understand the structure of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market by identifying its various subsegments.
3.Focuses on the key global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Research Report 2021, Forecast to 2026

1 Market Study Overview
1.1 Study Objectives
1.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation

2 Global Trend Summary
2.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Segment by Type
2.1.1 Invokana (Canagliflozin)
2.1.2 Jardiance (Empagliflozin)
2.1.3 Farxiga/Forxiga (Dapagliflozin)
2.1.4 Suglat (Ipragliflozin)
2.2 Market Analysis by Application
2.2.1 Hospital
2.2.2 Medical Research Institute
2.2.3 Other
2.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Comparison by Regions (2016-2026)
2.3.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size (2016-2026)
2.3.2 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Status and Prospect (2016-2026)
2.3.3 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Status and Prospect (2016-2026)
2.3.4 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Status and Prospect (2016-2026)
2.3.5 Japan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Status and Prospect (2016-2026)
2.3.6 Southeast Asia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Status and Prospect (2016-2026)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Industry Impact
2.5.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Business Impact Assessment - Covid-19
2.5.2 Market Trends and Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19

3 Competition by Manufacturer
3.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Market Share by Manufacturer (2016-2021)
3.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue and Market Share by Manufacturer (2016-2021)
3.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturer Market Share
3.5 Top 10 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market
3.7 Key Manufacturers Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Key Manufacturers
3.8 Mergers & Acquisitions Planning

4 Analysis of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Industry Key Manufacturers
4.1 Eli Lilly
4.1.1 Compan Detail
4.1.2 Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Introduction, Application and Specification
4.1.3 Eli Lilly 133 Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.1.4 Main Business Overview
4.1.5 Eli Lilly News
4.2 Janssen Pharmaceuticals
4.2.1 Compan Detail
4.2.2 Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Introduction, Application and Specification
4.2.3 Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.2.4 Main Business Overview
4.2.5 Eli Lilly News
4.3 Astellas
4.3.1 Compan Detail
4.3.2 Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Introduction, Application and Specification
4.3.3 Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.3.4 Main Business Overview
4.3.5 Astellas News
4.4 Boehringer Ingelheim
4.4.1 Compan Detail
4.4.2 Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Introduction, Application and Specification
4.4.3 Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.4.4 Main Business Overview
4.4.5 Boehringer Ingelheim News
4.5 AstraZeneca
4.5.1 Compan Detail
4.5.2 Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Introduction, Application and Specification
4.5.3 AstraZeneca Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.5.4 Main Business Overview
4.5.5 AstraZeneca News
4.6 Bristol Myers Squibb
4.6.1 Compan Detail
4.6.2 Bristol Myers Squibb Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Introduction, Application and Specification
4.6.3 Bristol Myers Squibb Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.6.4 Main Business Overview
4.6.5 Bristol Myers Squibb News
4.7 Kotobuki Pharmaceutical
4.7.1 Compan Detail
4.7.2 Kotobuki Pharmaceutical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Introduction, Application and Specification
4.7.3 Kotobuki Pharmaceutical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.7.4 Main Business Overview
4.7.4 Main Business Overview

5 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segment by Big Type
5.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, Sales and Market Share by Big Type (2016-2021)
5.1.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Market Share by Big Type (2016-2021)
5.1.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue and Market Share by Big Type (2016-2021)
5.2 Invokana (Canagliflozin) Sales Growth Rate and Price
5.2.1 Global Invokana (Canagliflozin) Sales Growth Rate (2016-2021)
5.2.2 Global Invokana (Canagliflozin) Price (2016-2021)
5.3 Jardiance (Empagliflozin) Sales Growth Rate and Price
5.3.1 Global Jardiance (Empagliflozin) Sales Growth Rate (2016-2021)
5.3.2 Global Jardiance (Empagliflozin) Price (2016-2021)
5.4 Farxiga/Forxiga (Dapagliflozin) Sales Growth Rate and Price
5.4.1 Global Farxiga/Forxiga (Dapagliflozin) Sales Growth Rate (2016-2021)
5.4.2 Global Farxiga/Forxiga (Dapagliflozin) Price (2016-2021)
5.5 Suglat (Ipragliflozin) Sales Growth Rate and Price
5.5.1 Global Suglat (Ipragliflozin) Sales Growth Rate (2016-2021)
5.5.2 Global Suglat (Ipragliflozin) Price (2016-2021)

6 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segment by Big Application
6.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Big Application (2016-2021)
6.2 Hospital Sales Growth Rate (2016-2021)
6.3 Medical Research Institute Sales Growth Rate (2016-2021)
6.4 Other Sales Growth Rate (2016-2021)

7 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Forecast
7.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, Sales and Growth Rate (2021-2026)
7.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Forecast by Regions (2021-2026)
7.2.1 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Forecast (2021-2026)
7.2.2 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Forecast (2021-2026)
7.2.3 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Forecast (2021-2026)
7.2.4 Japan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Forecast (2021-2026)
7.2.5 Southeast Asia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Forecast (2021-2026)
7.2.6 Other Regions Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Forecast (2021-2026)
7.3 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Forecast by Type (2021-2026)
7.3.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Type (2021-2026)
7.3.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share Forecast by Type (2021-2026)
7.4 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Forecast by Application (2021-2026)
7.4.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Application (2021-2026)
7.4.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share Forecast by Application (2021-2026)

8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis

9 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers

10 Research Findings and Conclusion

List of Tables and Figures

Figure Product Picture Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors
Figure Market Concentration Ratio and Market Maturity Analysis of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Big Type
Figure Global Market Share of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Big Type in 2020
Figure Invokana (Canagliflozin) Picture (2016-2021)
Figure Jardiance (Empagliflozin) Picture (2016-2021)
Figure Farxiga/Forxiga (Dapagliflozin) Picture (2016-2021)
Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Big Application
Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Application
Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Big Application in 2020
Figure Hospital Picture
Figure Medical Research Institute Picture
Figure Other Picture
Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Comparison by Regions (M USD) (2016-2026)
Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size (Million US$) (2016-2026)
Figure North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (Million US$) Growth Rate (2016-2026)
Figure Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (Million US$) Growth Rate (2016-2026)
Figure China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (Million US$) Growth Rate (2016-2026)
Figure Japan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (Million US$) Growth Rate (2016-2026)
Figure Southeast Asia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (Million US$) Growth Rate (2016-2026)
Table Business Impact Assessment - Covid-19
Table Market Trends and Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Manufacturer (2016-2021)
Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Manufacturer in 2020
Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Manufacturer (2016-2021)
Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Manufacturer in 2020
Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturer (Revenue) Market Share in 2020
Figure Top 10 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturer (Revenue) Market Share in 2020
Table Date of Key Manufacturers Enter into Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market
Table Key Manufacturers Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Type
Table Mergers & Acquisitions Planning
Table Eli Lilly Company Profile
Table Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Introduction, Application and Specification of Eli Lilly
Table Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2016-2021
Table Company One Main Business
Table Company One Recent Development
Table Janssen Pharmaceuticals Company Profile
Table Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Introduction, Application and Specification of Janssen Pharmaceuticals
Table Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Janssen Pharmaceuticals Recent Development
Table Astellas Company Profile
Table Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Introduction, Application and Specification of Astellas
Table Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Astellas Main Business
Table Astellas Recent Development
Table Boehringer Ingelheim Company Profile
Table Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Introduction, Application and Specification of Boehringer Ingelheim
Table Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Boehringer Ingelheim Main Business
Table Boehringer Ingelheim Recent Development
Table Boehringer Ingelheim Main Business
Table Boehringer Ingelheim Recent Development
Table AstraZeneca Company Profile
Table Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Introduction, Application and Specification of AstraZeneca
Table Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table AstraZeneca Main Business
Table AstraZeneca Recent Development
Table Bristol Myers Squibb Company Profile
Table Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Introduction, Application and Specification of Bristol Myers Squibb
Table Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Bristol Myers Squibb Main Business
Table Bristol Myers Squibb Recent Development
Table Kotobuki Pharmaceutical Company Profile
Table Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Introduction, Application and Specification of Kotobuki Pharmaceutical
Table Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Kotobuki Pharmaceutical Main Business
Table Kotobuki Pharmaceutical Recent Development
Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Growth Rate (2016-2021)
Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue and Growth Rate (2016-2021)
Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Regions (2016-2021)
Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Regions in 2020
Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Regions (2016-2021)
Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Regions in 2020
Figure North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Growth Rate (2016-2021)
Figure Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Growth Rate (2016-2021)
Figure China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Growth Rate (2016-2021)
Figure Japan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Growth Rate (2016-2021)
Figure Southeast Asia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Growth Rate (2016-2021)
Figure Other Regions Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Growth Rate (2016-2021)
Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Big Type (2016-2021)
Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Big Type (2016-2021)
Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Big Type in 2019
Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Big Type (2016-2021)
Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Big Type (2016-2021)
Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Big Type in 2019
Figure Global Invokana (Canagliflozin) Sales Growth Rate (2016-2021)
Figure Global Invokana (Canagliflozin) Price (2016-2021)
Figure Global Jardiance (Empagliflozin) Sales Growth Rate (2016-2021)
Figure Global Jardiance (Empagliflozin) Price (2016-2021)
Figure Global Farxiga/Forxiga (Dapagliflozin) Sales Growth Rate (2016-2021)
Figure Global Farxiga/Forxiga (Dapagliflozin) Price (2016-2021)
Figure Global Suglat (Ipragliflozin) Sales Growth Rate (2016-2021)
Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Big Application (2016-2021)
Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Big Application (2016-2021)
Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Big Application in 2019
Figure Global Hospital Sales Growth Rate (2016-2021)
Figure Global Medical Research Institute Sales Growth Rate (2016-2021)
Figure Global Other Sales Growth Rate (2016-2021)
Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Growth Rate (2021-2026)
Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue and Growth Rate (2021-2026)
Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Regions (2021-2026)
Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share Forecast by Regions (2021-2026)
Figure North America Sales Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Forecast (2021-2026)
Figure Europe Sales Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Forecast (2021-2026)
Figure China Sales Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Forecast (2021-2026)
Figure Japan Sales Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Forecast (2021-2026)
Figure Southeast Asia Sales Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Forecast (2021-2026)
Figure Other Regions Sales Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Forecast (2021-2026)
Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Type (2021-2026)
Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share Forecast by Type (2021-2026)
Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Application (2021-2026)
Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share Forecast by Application (2021-2026)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List

Eli Lilly
Janssen Pharmaceuticals
Astellas
Boehringer Ingelheim
AstraZeneca

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE